After more than two years of talks, hopes are high of completing an accord by November 15, though the heart of the document—how to share pathogens and vaccines—is set to be worked out later.
As we approach a new presidency, a new Congress and new leaders in our health agencies, I am concerned that the sense of urgency about COVID-19 appears to have faded. The disease has not been discussed during the election season, even though it is an ongoing and developing public health threat.
